vaccin
effect
method
prevent
infect
control
spread
ibv
current
avail
inactiv
attenu
viru
vaccin
disadvantag
develop
chimer
viruslik
particl
vlp
base
candid
vaccin
ibv
protect
chimer
vlp
compos
matrix
protein
avian
influenza
viru
fusion
protein
neuraminidas
na
spike
gener
fuse
ibv
protein
cytoplasm
transmembran
domain
na
protein
avian
influenza
viru
chimer
vlp
elicit
significantli
higher
antibodi
respons
intramuscularli
immun
mice
chicken
inactiv
ibv
virus
furthermor
chimer
vlp
induc
significantli
higher
neutral
antibodi
level
inactiv
viru
spf
chicken
final
chimer
vlp
induc
significantli
higher
product
mice
result
demonstr
chimer
vlp
potenti
use
vaccin
ibv
infect
infecti
bronchiti
viru
ibv
member
coronaviru
famili
preval
countri
intens
poultri
industri
ibv
highli
infecti
spread
rapidli
unprotect
bird
ibv
replic
epithelium
respiratori
tract
tissu
well
mani
nonrespiratori
tissu
kidney
gonad
larg
number
ibv
variant
worldwid
caus
great
econom
loss
poultri
industri
vaccin
effect
method
prevent
viru
infect
control
spread
ibv
inactiv
live
attenu
viru
vaccin
use
protect
chicken
ibv
inactiv
viru
vaccin
produc
ibvinfect
allanto
fluid
illicit
high
level
antibodi
respons
live
attenu
virus
offer
long
last
protect
immun
pose
risk
return
virul
form
coinfect
escherichia
coli
bacteria
accordingli
necessari
develop
new
ibv
vaccin
spike
protein
one
four
structur
protein
ibv
heavili
glycosyl
spike
glycoprotein
express
virion
surfac
protein
cleav
two
subunit
ntermin
ctermin
subunit
bulbou
head
protein
respons
attach
viru
cell
analysi
sspecif
monoclon
antibodi
shown
mani
amino
acid
viru
neutral
vn
epitop
locat
within
first
third
quarter
linear
polypeptid
immun
respons
induc
subunit
studi
use
protein
prepar
purifi
viru
deriv
baculovirusbas
express
system
viruslik
particl
vlp
multiprotein
structur
mimic
organ
conform
authent
nativ
virus
without
viral
genom
vlp
gener
assembl
structur
viral
protein
lipid
particl
vlp
wide
investig
use
develop
safe
effect
vaccin
viral
antigen
surfac
vlp
induc
humor
cellular
respons
two
vlpbase
vaccin
alreadi
licens
use
human
hepat
b
viru
hpv
vlpbase
vaccin
evalu
preclin
clinic
trial
addit
chimer
vlp
gener
substitut
part
extracellular
domain
surfac
antigen
vlp
deriv
one
viru
one
anoth
viru
vlp
shown
induc
immun
respons
surfac
antigen
viru
vlp
base
ibv
structur
protein
report
employ
investig
proteinprotein
interact
assembl
viron
influenza
viru
major
threat
human
health
caus
signific
morbid
mortal
worldwid
therefor
alway
forefront
vaccin
research
influenza
vlp
gener
coinfect
insect
cell
recombin
baculovirus
express
structur
influenza
protein
matrix
hemagglutinin
ha
haneuraminidas
na
influenza
vlp
found
induc
protect
immun
preclin
clinic
studi
light
find
studi
conduct
investig
whether
influenza
vlp
could
serv
platform
express
ibv
protein
whether
vlp
contain
protein
could
serv
candid
ibv
vaccin
studi
gener
fusion
protein
ibv
protein
fuse
cytoplasm
tail
ct
transmembran
tm
domain
avian
influenza
viru
na
protein
result
show
fusion
protein
avian
influenza
viru
protein
effici
assembl
form
chimer
vlp
chimer
vlp
prepar
quantit
use
immunogen
balbc
mice
spf
chicken
compar
ibv
inactiv
vaccin
chimer
vlp
induc
higher
immun
respons
taken
togeth
chimer
vlp
show
potenti
use
candid
vaccin
ibv
spodoptera
frugiperda
cell
maintain
grace
insect
cell
cultur
medium
gibco
usa
supplement
heatedinactiv
fetal
bovin
serum
fb
streptomycin
iuml
penicillin
c
humidifi
incub
ibv
strain
access
number
propag
specif
pathogen
free
spf
embryon
chicken
egg
briefli
gene
encod
na
protein
influenza
viru
access
protein
ibv
first
obtain
rtpcr
primescriptm
strand
cdna
synthesi
kit
takara
bio
china
clone
vector
obtain
recombin
plasmid
fusion
gene
gener
overlap
pcr
fulllength
fusion
gene
bp
contain
ct
tm
domain
na
bp
sequenc
bp
specif
primer
use
amplifi
ct
tm
domain
ccggaattcatgaatccaaatcagaa
forward
primer
gacccatattgagattagttttgtatg
revers
primer
primer
use
gener
caatat
gggtcatgtcgtactaccatc
forward
primer
acgcgtcgacacgtctaaaacgacgtgtt
revers
primer
two
pcr
product
mix
equal
gener
fusion
gene
pcr
use
forward
primer
revers
primer
nucleotid
sequenc
fusion
gene
confirm
dna
sequenc
clone
pfastbacdu
vector
invitrogen
usa
recombin
bacmid
gener
transform
recombin
pfastbacdu
vector
escherichia
coli
compet
cell
purifi
recombin
bacmid
dna
transfect
cell
cellfectin
reagent
invitrogen
day
recombin
baculovirus
obtain
supernat
subject
three
round
plaqu
purif
cell
densiti
per
flask
infect
multipl
infect
moi
h
mark
cytopath
effect
observ
infect
cell
infect
cell
harvest
analyz
western
blot
briefli
sampl
resolv
gradient
polyacrylamid
gel
fusion
protein
detect
chicken
polyclon
sera
ibv
viru
protein
detect
chicken
polyclon
sera
influenza
viru
horseradish
peroxidas
hrp
conjug
donkey
antichicken
secondari
antibodi
proteintech
group
usa
use
dilut
cell
infect
amount
wildtyp
baculoviru
treat
parallel
recombin
baculoviru
infect
cell
use
neg
control
cell
grown
mm
glass
coverslip
cultur
plate
infect
moi
h
fix
infect
cell
treat
control
cell
infect
wildtyp
baculovirus
process
parallel
sampl
express
fusion
protein
detect
chicken
polyclon
sera
ibv
viru
fitcconjug
donkey
antichicken
secondari
antibodi
fitc
green
beij
biosynthesi
biotechnolog
china
protein
detect
mous
polyclon
sera
influenza
viru
rabbit
antimous
secondari
antibodi
red
beij
biosynthesi
biotechnolog
nucleu
stain
dapi
beij
biosynthesi
biotechnolog
coverslip
mount
glass
slide
analyz
leica
confoc
laser
scan
microscop
produc
chimer
vlp
contain
fusion
protein
cell
coinfect
recombin
baculovirus
express
moi
cultur
supernat
harvest
h
postinfect
remov
cell
centrifug
g
min
vlp
supernat
pellet
ultracentrifug
g
h
resuspend
pb
particl
purifi
discontinu
sucros
gradient
g
h
c
purifi
vlp
collect
presenc
fusion
protein
protein
analyz
western
blot
describ
purifi
vlp
analyz
electron
microcopi
previous
describ
briefli
carbonco
copper
grid
float
drop
chimer
vlp
min
wash
water
three
time
next
phosphotungst
acid
ph
appli
min
neg
stain
gird
airdri
sampl
examin
transmiss
electron
microscopi
jeol
japan
magnif
three
group
femal
balbc
mice
n
intramuscularli
im
immun
chimer
vlp
inactiv
ibv
virus
pb
three
time
week
twoweek
interv
dose
chimer
vlp
inactiv
ibv
virus
contain
protein
plu
complet
freund
adjuv
cfa
primari
immun
incomplet
freund
adjuv
ifa
subsequ
boost
serum
sampl
collect
immun
day
immun
store
c
analysi
three
group
spf
chicken
n
im
immun
chimer
vlp
inactiv
ibv
virus
pb
twice
week
twoweek
interv
dose
chimer
vlp
inactiv
ibv
virus
contain
protein
plu
montanid
isa
seppic
franc
adjuv
serum
sampl
collect
immun
day
immun
store
c
analysi
serum
antibodi
analyz
enzymelink
immunosorb
assay
elisa
briefli
protein
purifi
cell
express
protein
well
plate
coat
wash
block
well
incub
serum
sampl
immun
mice
immun
spf
chicken
dilut
h
follow
wash
horseradish
peroxidas
hrp
label
rabbit
antimous
secondari
antibodi
proteintech
group
dilut
ad
incub
h
murin
sera
chicken
sera
hrplabel
donkey
antichicken
secondari
antibodi
proteintech
group
dilut
ad
incub
h
signal
visual
elisa
substrat
reagent
measur
nm
use
spectrophotomet
biotek
usa
murin
spleen
collect
sacrif
mice
day
third
immun
murin
splenocyt
obtain
use
mous
lymphocyt
separ
medium
dakew
biotech
china
number
specif
cell
secret
murin
murin
determin
elispot
assay
r
system
usa
splenocyt
stimul
purifi
ibv
viral
particl
concentr
number
spot
count
immunospot
elispot
reader
biosi
germani
serum
sampl
heatinactiv
c
min
twofold
serial
dilut
dilut
serum
sampl
mix
ibv
virus
tcid
tissu
cultur
infect
dose
incub
c
co
mixtur
serum
viru
inocul
spf
embryon
chicken
egg
neutral
titer
express
reciproc
highest
serum
dilut
neutral
ibv
spf
embryon
chicken
egg
valu
studi
present
mean
sd
statist
signific
among
group
determin
use
studentstwotail
test
p
consid
statist
signific
fusion
protein
compos
protein
amino
acid
without
signal
peptid
protein
ct
tm
domain
amino
acid
na
fig
fusion
protein
protein
express
cell
construct
fusion
protein
protein
amino
acid
fuse
ct
tm
domain
na
protein
b
western
blot
analysi
express
fusion
protein
cell
cell
infect
multipl
infect
moi
cell
lysat
separ
sdspage
probe
antibodi
one
clear
band
observ
molecular
mass
kd
correspond
mass
estim
accord
amino
acid
composit
c
western
blot
analysi
express
protein
cell
cell
infect
moi
cell
lysat
separ
sdspage
probe
antibodi
one
band
kd
shown
correspond
molecular
weight
nc
neg
control
fig
incorpor
fusion
protein
influenza
vlp
chimer
indirect
immunofluoresc
stain
cell
coinfect
moi
control
cell
infect
wt
bv
moi
infect
cell
fix
stain
antibodi
describ
materi
method
stain
fitc
green
protein
red
nucleu
dapi
blue
merg
indic
combin
three
pictur
magnif
use
b
protein
purifi
chimer
vlp
cell
coinfect
use
differ
combin
moi
give
ratio
infect
wt
bv
use
nc
supernat
collect
purifi
discontinu
sucros
step
densiti
gradient
centrifug
fraction
collect
analyz
western
blot
detect
c
neg
stain
electron
microscopi
chimer
vlp
compos
fusion
protein
scale
bar
nm
fig
serum
igg
elicit
chimer
vlp
inactiv
mice
sixweekold
balbc
mice
vaccin
via
intramuscular
inject
week
chimer
vlp
pb
serum
group
test
igg
antibodi
indirect
elisa
preimmun
sera
mice
dilut
time
analyz
detect
specif
antibodi
observ
optic
densiti
read
nm
bar
repres
arithmet
mean
antibodi
titer
standard
error
se
fig
elispot
assay
cytokinesecret
splenocyt
mice
splenocyt
isol
immun
mice
two
week
final
immun
restimul
inactiv
ibv
virus
cytokinesecret
cell
determin
elispot
assay
spot
cytokineproduc
cell
spleen
count
express
base
cell
per
well
protein
fig
estim
molecular
weight
mw
kd
fusion
protein
kd
protein
western
blot
analysi
show
detect
kd
band
fig
protein
appear
kd
band
fig
note
one
faint
kd
band
detect
togeth
protein
probe
chicken
polyclon
antibodi
whole
influenza
viru
suggest
chicken
polyclon
antibodi
could
react
ct
tm
domain
na
protein
nevertheless
result
demonstr
properli
express
cell
indirect
immunofluoresc
assay
confirm
coexpress
fitc
protein
coinfect
cell
fig
chimer
vlp
gener
coinfect
cell
optim
product
chimer
vlp
vari
combin
differ
moi
use
coinfect
cell
yield
vlp
determin
result
show
coinfect
moi
gener
optim
yield
fig
chimer
vlp
purifi
discontinu
sucros
densiti
gradient
electron
microscopi
use
examin
format
chimer
vlp
observ
vlp
diamet
nm
show
morpholog
characterist
similar
standard
influenza
vlp
fig
mous
serum
sampl
immun
chimer
vlp
inactiv
ibv
virus
dilut
time
analyz
igg
antibodi
elisa
purifi
protein
select
elisa
experi
protein
common
surfac
antigen
chimer
vlp
virus
therefor
measur
igg
antibodi
make
result
group
compar
addit
sinc
avail
standard
antigen
quantif
antibodi
difficult
accordingli
od
use
comparison
group
boost
increas
antibodi
respons
addit
chimer
fig
ibvspecif
neutral
antibodi
titer
immun
spf
chicken
serum
sampl
spf
chicken
collect
day
post
immun
ibv
mix
serial
dilut
sera
mixtur
inocul
spf
embryon
chicken
egg
neutral
titer
express
reciproc
highest
serum
dilut
exhibit
neutral
egg
fig
serum
igg
antibodi
tendayold
spf
chicken
intramuscularli
immun
twice
interv
chimer
vlp
pb
sera
test
igg
antibodi
elisa
preimmun
sera
spf
chicken
detect
antibodi
optic
densiti
read
nm
bar
repres
arithmet
mean
antibodi
titer
se
vlp
induc
higher
antibodi
respons
inactiv
ibv
virus
p
first
boost
fig
cellular
immun
respons
evalu
detect
number
splenocyt
secret
use
elispot
assay
singlecel
suspens
splenocyt
prepar
spleen
thricevaccin
mice
stimul
inactiv
viru
result
show
chimer
vlp
elicit
higher
level
product
inactiv
virus
p
fig
induc
compar
product
fig
suggest
chimer
vlp
could
elicit
type
cellular
immun
respons
mice
ibvspecif
neutral
antibodi
titer
measur
serum
sampl
collect
day
second
boost
chimer
vlp
inactiv
viru
group
higher
neutral
titer
pb
group
p
howev
chimer
vlp
inactiv
group
differ
significantli
p
although
vlp
group
slightli
higher
neutral
antibodi
titer
serum
igg
antibodi
titer
determin
elisa
show
chimer
vlp
effici
stimul
total
antibodi
inactiv
virus
fig
chimer
vlp
group
inactiv
virus
group
exhibit
higher
level
antibodi
pb
control
group
p
addit
level
antibodi
chimer
vlp
group
higher
group
p
serum
ibvspecif
neutral
antibodi
titer
chicken
measur
serum
sampl
vaccin
spf
chicken
day
boost
immun
compar
pb
group
chimer
vlp
inactiv
virus
group
higher
neutral
antibodi
titer
p
chimer
vlp
higher
inactiv
group
p
fig
studi
investig
whether
chimer
vlp
express
ibv
protein
surfac
could
gener
cell
result
show
chimer
vlp
could
assembl
coexpress
fusion
protein
influenza
viru
protein
also
provid
evid
demonstr
chimer
vlp
immunogen
induc
antibodi
respons
higher
level
inactiv
virus
furthermor
chimer
vlp
could
induc
significantli
higher
cellular
immunerespons
inactiv
virus
ibv
enorm
econom
impact
commerci
poultri
caus
highli
contagi
diseas
chicken
age
vaccin
use
control
ib
half
centuri
although
inactiv
attenu
viru
vaccin
contribut
immens
control
ib
drawback
exampl
attenu
viru
vaccin
pose
potenti
hazard
propag
viru
via
embryon
chicken
egg
therefor
risk
spread
viru
gener
stronger
form
despit
risk
inactiv
viru
vaccin
commonli
use
combin
attenu
viru
vaccin
induc
high
level
antibodi
chimer
vlp
promis
develop
field
vlp
research
exampl
newcastl
diseas
vlp
contain
respiratori
syncyti
viru
protein
membraneanchor
flagellin
incorpor
influenza
vlp
present
studi
demonstr
fusion
protein
could
success
assembl
bud
influenza
form
chimer
vlp
chimer
vlp
similar
previous
report
influenza
vlp
accordingli
result
present
herein
provid
addit
exampl
support
feasibl
gener
chimer
vlp
studi
demonstr
chimer
vlp
induc
robust
humor
respons
obvious
higher
level
inactiv
virus
mice
chicken
p
addit
higher
level
detect
vlp
group
inactiv
group
p
although
mechan
chimer
vlp
elicit
significantli
higher
product
inactiv
virus
clear
furthermor
chimer
vlp
induc
significantli
higher
neutral
antibodi
titer
inactiv
ibv
virus
summari
studi
demonstr
gener
chimer
vlp
express
ibv
protein
surfac
influenza
vlp
result
show
chimer
vlp
could
elicit
humor
cellular
immun
respons
neutral
antibodi
respons
level
significantli
higher
inactiv
ibv
virus
accordingli
chimer
vlp
potenti
candid
develop
vaccin
ibv
